US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 30.480
  • +0.980+3.32%
Close Feb 14 16:00 ET
  • 30.500
  • +0.020+0.07%
Post 19:59 ET
3.40BMarket Cap-30.18P/E (TTM)

About Viking Therapeutics Company

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Company Profile

SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660
Websitehttp://www.vikingtherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian Lian, PhD
  • President, Chief Executive Officer and Director
  • 12.63M
  • Marianne Mancini
  • Chief Operating Officer
  • 3.51M
  • Greg S. Zante
  • Chief Financial Officer and Principal Accounting Officer
  • 3.50M
  • J. Matthew Singleton
  • Independent Director
  • 192.77K
  • Charles A. Rowland, Jr,M.B.A.
  • Independent Director
  • 189.62K
  • Dr. S. Kathryn Rouan, PhD
  • Independent Director
  • 178.65K
  • Matthew W. Foehr
  • Independent Director
  • 169.37K
  • Dr. Lawson Macartney, D.V.M.,PhD
  • Chairperson of the Board
  • 222.72K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!